Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
BioNTech
BNTX
|
$1.04B |
| 2 |
Sea Limited
SE
|
$874M |
| 3 |
Okta
OKTA
|
$783M |
| 4 |
XYZ
Block, Inc.
XYZ
|
$699M |
| 5 |
HubSpot
HUBS
|
$666M |
Top Sells
| 1 |
Match Group
MTCH
|
$958M |
| 2 |
Union Pacific
UNP
|
$614M |
| 3 |
Spotify
SPOT
|
$550M |
| 4 |
Amazon
AMZN
|
$446M |
| 5 |
RingCentral
RNG
|
$428M |
Sector Composition
| 1 | Technology | 35.17% |
| 2 | Consumer Discretionary | 23.11% |
| 3 | Communication Services | 15.59% |
| 4 | Healthcare | 8.54% |
| 5 | Financials | 8.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
FARO
426
DELISTED
Faro Technologies
FARO
| $12.7M | 0.01% |
193,636
+39,863
| +26% | +$2.62M |
|
427
Toast
TOST
$24B
| $12.5M | 0.01% |
+250,000
| New | +$12.5M |
|
428
BioLife Solutions
BLFS
$1.27B
| $12.5M | 0.01% |
294,335
-10,023
| -3% | -$424K |
|
429
Royal Gold
RGLD
$12.2B
| $12.4M | 0.01% |
129,711
+193
| +0.1% | +$18.4K |
|
430
Concrete Pumping Holdings
BBCP
$397M
| $12.1M | 0.01% |
1,414,722
+12,820
| +0.9% | +$109K |
|
|
IMAB
431
I-MAB
IMAB
$358M
| $12.1M | 0.01% |
166,485
-3,775
| -2% | -$274K |
|
|
NOVA
432
DELISTED
Sunnova Energy
NOVA
| $12M | 0.01% |
364,871
+3,590
| +1% | +$118K |
|
433
Wabtec
WAB
$33B
| $12M | 0.01% |
138,907
-606
| -0.4% | -$52.2K |
|
434
Denali Therapeutics
DNLI
$2.26B
| $11.5M | 0.01% |
228,422
-146,090
| -39% | -$7.37M |
|
435
Lattice Semiconductor
LSCC
$9.05B
| $11.4M | 0.01% |
176,528
-174,511
| -50% | -$11.3M |
|
436
SOPHiA GENETICS
SOPH
$219M
| $11.3M | 0.01% |
+645,417
| New | +$11.3M |
|
437
Mueller Water Products
MWA
$4.19B
| $11.3M | 0.01% |
739,880
+77,432
| +12% | +$1.18M |
|
|
PSXP
438
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
| $11.2M | 0.01% |
312,714
-3,060
| -1% | -$110K |
|
|
XEC
439
DELISTED
CIMAREX ENERGY CO
XEC
| $11M | 0.01% |
125,919
-51,354
| -29% | -$4.48M |
|
440
Utz Brands
UTZ
$1.19B
| $10.9M | 0.01% |
638,764
-58,257
| -8% | -$998K |
|
|
CVET
441
DELISTED
Covetrus, Inc. Common Stock
CVET
| $10.9M | 0.01% |
602,848
-76,764
| -11% | -$1.39M |
|
442
Kymera Therapeutics
KYMR
$3.11B
| $10.8M | 0.01% |
184,581
-2,120
| -1% | -$125K |
|
|
KRTX
443
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $10.8M | 0.01% |
+88,341
| New | +$10.8M |
|
444
Valero Energy
VLO
$48.7B
| $10.8M | 0.01% |
152,977
-38,210
| -20% | -$2.7M |
|
445
Nutrien
NTR
$27.4B
| $10.8M | 0.01% |
166,460
+1,717
| +1% | +$111K |
|
446
Bunge Global
BG
$16.9B
| $10.6M | 0.01% |
130,724
+599
| +0.5% | +$48.7K |
|
447
PMV Pharmaceuticals
PMVP
$77.4M
| $10.6M | 0.01% |
354,049
-4,103
| -1% | -$122K |
|
|
B
448
Barrick Mining Corporation
B
$48.5B
| $10.5M | 0.01% |
580,955
-62,804
| -10% | -$1.13M |
|
449
Halliburton
HAL
$18.8B
| $10.3M | 0.01% |
477,635
+1,388
| +0.3% | +$30K |
|
450
Integra LifeSciences
IART
$1.25B
| $10.3M | 0.01% |
149,965
-172,545
| -54% | -$11.8M |
|